Bridgewater Associates LP Has Lowered Its Kohls (KSS) Position; Sangamo Therapeutics (SGMO) Shorts Increased By 5.67%

July 17, 2017 - By Darrin Black

Bridgewater Associates Lp decreased Kohls Corp (KSS) stake by 79.37% reported in 2016Q4 SEC filing. Bridgewater Associates Lp sold 248,526 shares as Kohls Corp (KSS)’s stock declined 10.79%. The Bridgewater Associates Lp holds 64,610 shares with $3.19 million value, down from 313,136 last quarter. Kohls Corp now has $6.79B valuation. The stock rose 2.94% or $1.14 reaching $39.95. About 2.15 million shares traded. Kohl’s Corporation (NYSE:KSS) has risen 7.16% since July 17, 2016 and is uptrending. It has underperformed by 9.54% the S&P500.

Sangamo Therapeutics Incorporated (NASDAQ:SGMO) had an increase of 5.67% in short interest. SGMO’s SI was 9.80M shares in July as released by FINRA. Its up 5.67% from 9.27 million shares previously. With 726,300 avg volume, 14 days are for Sangamo Therapeutics Incorporated (NASDAQ:SGMO)’s short sellers to cover SGMO’s short positions. The SI to Sangamo Therapeutics Incorporated’s float is 14.83%. About 722,710 shares traded. Sangamo Therapeutics Inc (NASDAQ:SGMO) has risen 29.78% since July 17, 2016 and is uptrending. It has outperformed by 13.08% the S&P500.

Investors sentiment decreased to 1.15 in 2016 Q4. Its down 0.06, from 1.21 in 2016Q3. It dropped, as 17 investors sold Sangamo Therapeutics Inc shares while 31 reduced holdings. 18 funds opened positions while 37 raised stakes. 39.96 million shares or 8.31% less from 43.58 million shares in 2016Q3 were reported. Wasatch Advsrs has 7.26 million shares. California Pub Employees Retirement Sys holds 0% or 119,300 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0% in Sangamo Therapeutics Inc (NASDAQ:SGMO) or 2,347 shares. Grp One Trading Limited Partnership has invested 0.01% in Sangamo Therapeutics Inc (NASDAQ:SGMO). Two Sigma Secs Lc invested in 21,733 shares. Art Advsrs Ltd Liability Com accumulated 53,046 shares or 0.01% of the stock. Da Davidson And reported 5,751 shares. Us National Bank De invested in 5,000 shares or 0% of the stock. Blackrock Investment Mgmt Ltd reported 277,184 shares. Voya Invest Ltd Limited Liability Company reported 30,539 shares or 0% of all its holdings. Geode Cap Management Ltd Limited Liability Company stated it has 614,633 shares or 0% of all its holdings. California State Teachers Retirement Sys reported 0% of its portfolio in Sangamo Therapeutics Inc (NASDAQ:SGMO). Great West Life Assurance Can holds 5,100 shares. Northwestern Mutual Wealth Mngmt Company stated it has 100 shares. State Common Retirement Fund reported 0% in Sangamo Therapeutics Inc (NASDAQ:SGMO).

Since May 11, 2017, it had 0 buys, and 2 insider sales for $34,754 activity. The insider Herberts Curt A. III sold $13,600.

Among 9 analysts covering Sangamo Biosciences (NASDAQ:SGMO), 4 have Buy rating, 1 Sell and 4 Hold. Therefore 44% are positive. Sangamo Biosciences had 13 analyst reports since August 8, 2015 according to SRatingsIntel. Wedbush downgraded Sangamo Therapeutics Inc (NASDAQ:SGMO) rating on Tuesday, November 1. Wedbush has “Neutral” rating and $4 target. Piper Jaffray downgraded the shares of SGMO in report on Wednesday, October 19 to “Neutral” rating. The stock of Sangamo Therapeutics Inc (NASDAQ:SGMO) has “Buy” rating given on Wednesday, September 2 by Wedbush. JP Morgan maintained Sangamo Therapeutics Inc (NASDAQ:SGMO) rating on Saturday, August 8. JP Morgan has “Overweight” rating and $22 target. Jefferies reinitiated the shares of SGMO in report on Thursday, June 22 with “Buy” rating. As per Friday, September 4, the company rating was maintained by Cowen & Co. Jefferies maintained Sangamo Therapeutics Inc (NASDAQ:SGMO) rating on Wednesday, September 2. Jefferies has “Buy” rating and $12 target. PiperJaffray downgraded Sangamo Therapeutics Inc (NASDAQ:SGMO) on Wednesday, October 19 to “Neutral” rating. As per Thursday, August 4, the company rating was downgraded by Janney Capital. On Tuesday, September 8 the stock rating was downgraded by Zacks to “Sell”.

Sangamo Therapeutics, Inc., formerly Sangamo BioSciences, Inc., is a clinical-stage biotechnology company. The company has market cap of $843.08 million. The Firm is focused on translating science into genomic therapies that transform patients’ lives using the Company’s platform technologies in genome editing, gene therapy, gene regulation and cell therapy. It currently has negative earnings. The Firm has clinical and preclinical programs in development and partnered certain programs with biopharmaceutical companies to expedite clinical and commercial development.

Bridgewater Associates Lp increased Royal Gold Inc (NASDAQ:RGLD) stake by 22,400 shares to 77,900 valued at $4.94M in 2016Q4. It also upped Vanguard Intl Equity Index F (VWO) stake by 11.79 million shares and now owns 92.20 million shares. Oracle Corp (NYSE:ORCL) was raised too.

Since March 2, 2017, it had 0 insider purchases, and 1 sale for $619,057 activity. SICA FRANK V also sold $619,057 worth of Kohl’s Corporation (NYSE:KSS) on Thursday, March 2.

Investors sentiment decreased to 1.03 in Q4 2016. Its down 0.11, from 1.14 in 2016Q3. It turned negative, as 50 investors sold KSS shares while 189 reduced holdings. 80 funds opened positions while 166 raised stakes. 178.89 million shares or 4.03% more from 171.95 million shares in 2016Q3 were reported. City Hldgs owns 24,700 shares. Blackrock Grp Ltd invested 0.05% in Kohl’s Corporation (NYSE:KSS). Integrated Wealth Counsel Ltd Company holds 176 shares. State Of New Jersey Common Pension Fund D owns 68,000 shares. First Dallas Secs reported 5,600 shares stake. Botty Investors Ltd Liability Corp invested in 0.34% or 11,650 shares. Sei Co holds 0.03% of its portfolio in Kohl’s Corporation (NYSE:KSS) for 133,466 shares. Washington National Bank has 19 shares for 0% of their portfolio. Gateway Advisers Ltd Company stated it has 0.01% in Kohl’s Corporation (NYSE:KSS). Geode Cap Mngmt Ltd Liability holds 0.04% of its portfolio in Kohl’s Corporation (NYSE:KSS) for 1.96M shares. Bnp Paribas Investment Sa holds 55,707 shares. Caisse De Depot Et Placement Du Quebec, a Quebec – Canada-based fund reported 158,800 shares. Blair William Il stated it has 120,528 shares. South Dakota Invest Council holds 0.31% or 300,464 shares. North Star Corporation has invested 0% in Kohl’s Corporation (NYSE:KSS).

Among 20 analysts covering Kohl’s Corporation (NYSE:KSS), 6 have Buy rating, 4 Sell and 10 Hold. Therefore 30% are positive. Kohl’s Corporation had 52 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Neutral” rating given on Friday, May 5 by Atlantic Securities. The stock of Kohl’s Corporation (NYSE:KSS) earned “Sell” rating by RBC Capital Markets on Monday, June 19. As per Wednesday, October 7, the company rating was initiated by Citigroup. Citigroup upgraded Kohl’s Corporation (NYSE:KSS) on Monday, November 14 to “Buy” rating. The rating was downgraded by Robert W. Baird on Thursday, January 5 to “Neutral”. The stock has “Buy” rating by Guggenheim on Friday, September 30. RBC Capital Markets maintained Kohl’s Corporation (NYSE:KSS) on Friday, May 12 with “Underperform” rating. The rating was maintained by M Partners with “Buy” on Tuesday, November 10. The stock of Kohl’s Corporation (NYSE:KSS) earned “Buy” rating by M Partners on Friday, August 14. The firm has “Outperform” rating given on Friday, August 14 by Telsey Advisory Group.

Analysts await Kohl’s Corporation (NYSE:KSS) to report earnings on August, 10 before the open. They expect $1.15 EPS, down 5.74% or $0.07 from last year’s $1.22 per share. KSS’s profit will be $195.46 million for 8.68 P/E if the $1.15 EPS becomes a reality. After $0.39 actual EPS reported by Kohl’s Corporation for the previous quarter, Wall Street now forecasts 194.87% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: